TRVI
TRVI
US89532M1018
Trevi Therapeutics, Inc.
Loading chart...

Valuation & History

Quarterly trend of key valuation metrics

Metric
Current (TTM) TTM Baseline
Q2 '26 30.06.2026
Q1 '26 31.03.2026
Q4 '25 31.12.2025
Market & Enterprise Value
Market Cap
1.88B EUR
2.65B EUR
1.53B EUR
1.61B EUR
Enterprise Value
1.51B EUR
2.59B EUR
1.51B EUR
1.59B EUR
Valuation Multiples
Trailing P/E
--
--
--
--
Forward P/E
-22.86x
--
--
--
Price to Sales
--
--
--
--
Price to Book
5.84x
8.24x
8.9x
8.77x
EV/Revenue
--
--
--
--
EV/EBITDA
-25.4x
--
--
--
Price to FCF (P/FCF)
--
--
--
--
EV/FCF
--
--
--
--
FCF Yield
-1.77%
-2%
-2.96%
-1.78%
ende